Tyk2 Inhibitor Market - Novel Allosteric Inhibition Reshaping Autoimmune Disease Treatment Paradigms
Market Overview The tyk2 inhibitor market is evolving rapidly as novel allosteric inhibition reshapes autoimmune disease treatment paradigms. The Tyk2 Inhibitor Market is projected to grow from USD 2.15 billion in 2025 to USD 5.7 billion by 2035, driven by deucravacitinib adoption, expanding psoriatic arthritis indication, and pipeline candidates advancing through clinical development. Current...
0 Commentaires 0 Parts 5 Vue 0 Aperçu
BuzzingAbout https://www.buzzingabout.com